Perbedaan Sinergi Inti Plastindo Tbk. dan Charlie Hospital Semarang Tbk.: Sinergi Inti Plastindo Tbk. diperdagangkan di Rp128 (kapitalisasi pasar 139,85 M, volume 24 jam 66,98 jt), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp256 (kapitalisasi pasar 715,5 M, volume 24 jam 30,64 jt). Perbedaan utamanya: Charlie Hospital Semarang Tbk. jauh lebih besar — sekitar 5,1× kapitalisasi pasar Sinergi Inti Plastindo Tbk., dan Sinergi Inti Plastindo Tbk. lebih aktif diperdagangkan (66,98 jt vs 30,64 jt). Mana yang lebih baik tergantung tujuan investasimu.
| ESIP | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 139,85 M | 715,5 M |
Volume | 66,98 jt | 30,64 jt |
Lot | 669,81 rb | 306,41 rb |
Perputaran | 8,73 M | 7,98 M |
Harga Rata-rata | 130,29 | 260,34 |
Nilai Transaksi | 8,73 M | 7,98 M |
Harga Ekuilibrium Indikatif | 128 | 256 |
Volume Ekuilibrium Indikatif | 7,61 rb | 512 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Selengkapnya di halaman ESIP →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →